BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23380709)

  • 1. Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.
    Roeker LE; Larson DR; Kyle RA; Kumar S; Dispenzieri A; Rajkumar SV
    Leukemia; 2013 Jun; 27(6):1391-3. PubMed ID: 23380709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).
    Mailankody S; Pfeiffer RM; Kristinsson SY; Korde N; Bjorkholm M; Goldin LR; Turesson I; Landgren O
    Blood; 2011 Oct; 118(15):4086-92. PubMed ID: 21795746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of monoclonal gammopathy and myelodysplasia: a retrospective study of fourteen cases.
    Yoshida Y; Oguma S; Ohno H; Nakabo Y; Katsurada T; Kawahara M; Kawabata H
    Int J Hematol; 2014 Jun; 99(6):721-5. PubMed ID: 24687918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
    Castillo JJ; Gertz MA
    Leuk Lymphoma; 2017 Apr; 58(4):773-780. PubMed ID: 27546465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Nolte F; Mossner M; Jann JC; Nowak D; Boch T; Müller NZ; Hofmann WK; Metzgeroth G
    Eur J Haematol; 2017 Mar; 98(3):302-310. PubMed ID: 27862375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review.
    Yan W; Qu XY; Li H; Li YC; Li Y; Yao K; Yang W; Wang HH
    Ann Palliat Med; 2021 Dec; 10(12):12431-12440. PubMed ID: 35016480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners.
    McShane CM; Murphy B; Santin O; Anderson LA
    BMC Fam Pract; 2019 May; 20(1):61. PubMed ID: 31088396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
    Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
    J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition.
    Therneau TM; Kyle RA; Melton LJ; Larson DR; Benson JT; Colby CL; Dispenzieri A; Kumar S; Katzmann JA; Cerhan JR; Rajkumar SV
    Mayo Clin Proc; 2012 Nov; 87(11):1071-9. PubMed ID: 22883742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
    Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute venous thromboembolic events in patients with monoclonal gammopathy of undetermined significance: An analysis of the National Inpatient Sample.
    Abdelhay A; Mahmoud AA; Mostafa M; Al Ali O; Gill S; Jamshed S
    Thromb Res; 2023 May; 225():28-32. PubMed ID: 36933476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.